Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic target

Abdelwahab, E. M. M.Pal, SunitaKvell, KrisztiánSárosi, VeronikaBai, PéterRue, R.Krymskaya, V.McPhail, D.Porter, A.Pongrácz, Judit2019-02-062019-02-062019Oncogene. -38 (2019), p. 3093-3101. -Oncogene. - 0950-92320950-9232http://hdl.handle.net/2437/263588Mitochondrial dysfunction is a key determinant of the rare disease lymphangioleiomyomatosis and provides a novel therapeutic targetfolyóiratcikkopen access articlehttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM076959OrvostudományokElméleti orvostudományokhttp://dx.doi.org/10.1038/s41388-018-0625-12019-06-2000046516760001585058854414